Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema (left eye)
ICD-10 E09.3492 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema (left eye).
E09.3492 refers to diabetes mellitus that has been induced by drugs or chemicals, characterized by severe nonproliferative diabetic retinopathy in the left eye without macular edema. This condition arises when certain medications or toxic substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The severe nonproliferative diabetic retinopathy indicates significant retinal damage due to prolonged hyperglycemia, which can lead to vision impairment if not managed properly. The absence of macular edema suggests that while there is retinal damage, the central vision area remains unaffected. Management of this condition typically involves controlling blood glucose levels through lifestyle modifications, monitoring HbA1c levels, and possibly insulin therapy, depending on the severity of the diabetes. Regular ophthalmologic evaluations are crucial to monitor the progression of retinopathy and to prevent further complications.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes due to medication, requiring insulin management.
Ensure clear documentation of the drug responsible for diabetes onset.
Retinal examination findings, severity of retinopathy, and treatment plans.
Patients with diabetes presenting for routine eye exams or vision changes.
Document specific findings related to nonproliferative retinopathy and absence of macular edema.
Used for routine eye exams in patients with diabetes.
Document findings related to retinopathy and any treatment plans.
Ophthalmologists should ensure comprehensive documentation of diabetic eye disease.
Medications such as corticosteroids, certain antipsychotics, and some chemotherapy agents can induce diabetes by affecting insulin sensitivity or secretion.
Diabetic retinopathy is classified into nonproliferative and proliferative stages, with nonproliferative retinopathy further categorized by severity based on retinal findings.
